NCT00944372View on ClinicalTrials.gov

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

PHASE4TerminatedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Solid Tumors
Interventions
DRUG

Indium In-111 pentetreotide

Single intravenous injection of 222MBq (6.0 mCi) Indium In-111 pentetreotide

Trial Locations (4)

19104

Hospital of University of Pennsylvania, Division of Nuclear Medicine, Philadelphia

33136

University of Miami, Jackson Memorial Hospital, Miami

52242

University of Iowa Medical Center, Iowa City

70112

Louisiana State University, Division of Hem/Onc, New Orleans

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT00944372 - Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors | Biotech Hunter | Biotech Hunter